HIGHLIGHTS
- who: . and collaborators from the University of Rzeszow, Poland have published the article: Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders, in the Journal: (JOURNAL)
SUMMARY
Of CNS disorders, including cerebral ischemia, intracerebral hemorrhage, traumatic brain injury (TBI), Alzheimer`s disease (AD), Parkinson`s disease (PD), epilepsy, depression, multiple_sclerosis, morphine tolerance, and glioma. Because the regulatory effects and possible mechanisms of sinomenine in pain have been well studied and discussed in previous studies (Gao et_al, 2013; Zhu et_al, 2016; Gao et_al, 2019b; Jiang et_al, 2020; Gao et_al, 2021 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.